• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Statin Use Shows Increased Overall Survival in Patients Diagnosed With Pancreatic Cancer: A Meta-Analysis.

作者信息

Wang Danlu, Rodriguez Eduardo A, Barkin Jamie S, Donath Elie M, Pakravan Ali S

机构信息

Department of Medicine University of Miami/JFK Medical Center Palm Beach Regional GME Consortium Atlantis, FL

出版信息

Pancreas. 2019 Apr;48(4):e22-e23. doi: 10.1097/MPA.0000000000001276.

DOI:10.1097/MPA.0000000000001276
PMID:30973465
Abstract
摘要

相似文献

1
Statin Use Shows Increased Overall Survival in Patients Diagnosed With Pancreatic Cancer: A Meta-Analysis.他汀类药物的使用显示可提高胰腺癌患者的总生存率：一项荟萃分析。
Pancreas. 2019 Apr;48(4):e22-e23. doi: 10.1097/MPA.0000000000001276.
2
Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.二甲双胍和他汀类药物对老年胰腺腺癌患者总生存期的差异及联合效应：一项基于大人群的研究
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1225-1232. doi: 10.1158/1055-9965.EPI-17-0227. Epub 2017 Jun 15.
3
Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.二甲双胍和他汀类药物使用对胰腺癌患者生存的影响：系统文献回顾和荟萃分析。
Curr Med Chem. 2018;25(22):2595-2607. doi: 10.2174/0929867324666170412145232.
4
The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.癌症诊断后使用他汀类药物与胰腺癌患者生存率的关联：一项监测、流行病学和最终结果（SEER）医保分析
PLoS One. 2015 Apr 1;10(4):e0121783. doi: 10.1371/journal.pone.0121783. eCollection 2015.
5
HMG-CoA reductase inhibitors for the treatment of pancreatic cancer.用于治疗胰腺癌的HMG-CoA还原酶抑制剂。
Gastroenterology. 2002 Feb;122(2):565-7. doi: 10.1053/gast.2002.31473.
6
Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies.他汀类药物治疗转移性胰腺癌的疗效和结局：两项 III 期研究的汇总分析。
Clin Transl Oncol. 2019 Jun;21(6):810-816. doi: 10.1007/s12094-018-1992-3. Epub 2018 Nov 21.
7
Survival Benefits From Metformin Use in Pancreatic Cancer: A Systemic Review and Meta-analysis.二甲双胍用于胰腺癌的生存获益：一项系统评价和荟萃分析。
Pancreas. 2018 Mar;47(3):e11-e14. doi: 10.1097/MPA.0000000000001000.
8
Statin Use and Risk of Pancreatic Cancer: An Updated Meta-analysis of 26 Studies.他汀类药物的使用与胰腺癌风险：26项研究的最新荟萃分析
Pancreas. 2019 Feb;48(2):142-150. doi: 10.1097/MPA.0000000000001226.
9
Very Early Onset Pancreatic Adenocarcinoma - Clinical Presentation, Risk Factors and Therapeutic Options.极早期胰腺癌——临床表现、危险因素及治疗选择
Chirurgia (Bucur). 2018 May-Jun;113(3):405-411. doi: 10.21614/chirurgia.113.3.405.
10
Statin Use and the Overall Survival in Patients Diagnosed With Pancreatic Cancer.他汀类药物的使用与胰腺癌确诊患者的总生存率
Pancreas. 2020 Feb;49(2):e19. doi: 10.1097/MPA.0000000000001469.

引用本文的文献

1
Employing Bidirectional Two-Sample Mendelian Randomization Analysis to Verify the Potential of Polyunsaturated Fatty Acid Levels in the Prevention of Pancreatic Cancer.采用双向双样本孟德尔随机化分析验证多不饱和脂肪酸水平在预防胰腺癌中的潜力。
Curr Issues Mol Biol. 2024 Jun 14;46(6):6041-6051. doi: 10.3390/cimb46060360.
2
Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune suppression by downregulating PD-L1 expression in pancreatic cancer.他汀类药物通过JNK信号激活抑制YAP/TAZ表达发挥抗生长作用，并通过下调胰腺癌中PD-L1的表达消除免疫抑制。
Am J Cancer Res. 2023 May 15;13(5):2041-2054. eCollection 2023.
3
PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer.
PI3K/AKT/mTOR信号通路及其相关分子参与了PROK1沉默诱导的对胰腺癌的抗肿瘤作用。
Open Life Sci. 2023 Apr 10;18(1):20220538. doi: 10.1515/biol-2022-0538. eCollection 2023.
4
Lipid metabolism in pancreatic cancer: emerging roles and potential targets.胰腺癌中的脂代谢：新出现的作用和潜在靶点。
Cancer Commun (Lond). 2022 Dec;42(12):1234-1256. doi: 10.1002/cac2.12360. Epub 2022 Sep 15.
5
An Update on Common Pharmaceuticals in the Prevention of Pancreatic Cancer.预防胰腺癌常用药物的最新进展
Cureus. 2022 May 30;14(5):e25496. doi: 10.7759/cureus.25496. eCollection 2022 May.
6
Statins and the risk of pancreatic cancer: A systematic review and meta-analysis of 2,797,186 patients.他汀类药物与胰腺癌风险：2797186 例患者的系统评价和荟萃分析。
Cardiol J. 2024;31(2):243-250. doi: 10.5603/CJ.a2022.0014. Epub 2022 Apr 4.
7
Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis.双膦酸盐的使用并不会影响胰腺癌患者的生存：一项倾向评分匹配分析。
Gut Liver. 2021 Sep 15;15(5):782-790. doi: 10.5009/gnl20297.
8
Do statins play any role in reducing the incidence and mortality of ovarian cancer? A systematic review and meta-analysis.他汀类药物在降低卵巢癌发病率和死亡率方面起作用吗？一项系统评价与荟萃分析。
J Prev Med Hyg. 2020 Oct 6;61(3):E331-E339. doi: 10.15167/2421-4248/jpmh2020.61.3.1497. eCollection 2020 Sep.
9
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.胰腺循环肿瘤细胞分析鉴定 LIN28B 为转移驱动因子和药物靶点。
Nat Commun. 2020 Jul 3;11(1):3303. doi: 10.1038/s41467-020-17150-3.